[Federal Register Volume 83, Number 145 (Friday, July 27, 2018)]
[Notices]
[Pages 35666-35667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16112]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke, Muscular 
Dystrophy Coordinating Committee Call for Committee Membership 
Nominations

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Office of the Secretary of the Department of Health and 
Human Services (HHS) is seeking nominations for an individual to serve 
as a nonfederal public member on the Muscular Dystrophy Coordinating 
Committee.

DATES: Nominations are due by 5 p.m. EDT on August 31, 2018.

ADDRESSES: Nominations must be sent to Glen Nuckolls, Ph.D., by email 
to <a href="/cdn-cgi/l/email-protection#325c4751595d5e5e55725c5b5c56411c5c5b5a1c555d44"><span class="__cf_email__" data-cfemail="e08e95838b8f8c8c87a08e898e8493ce8e8988ce878f96">[email protected]</span></a>.

FOR FURTHER INFORMATION CONTACT: Glen Nuckolls, Ph.D., by email to 
<a href="/cdn-cgi/l/email-protection#0a647f69616566666d4a6463646e7924646362246d657c"><span class="__cf_email__" data-cfemail="cca2b9afa7a3a0a0ab8ca2a5a2a8bfe2a2a5a4e2aba3ba">[email protected]</span></a>. or (301) 496-5745.

SUPPLEMENTARY INFORMATION: The Muscular Dystrophy Coordinating 
Committee (MDCC) is a federal advisory committee established in 
accordance with the Muscular Dystrophy Community Assistance, Research, 
and Education Amendments of 2001 (MD-CARE Act; Pub. L. 107-84). The MD-
CARE Act was reauthorized in 2008 by Public Law 110-361, and again in 
2014 by Public Law 113-166. The MD-CARE Act specifies that the 
committee membership be composed of \2/3\ governmental agency 
representatives and \1/3\ public members. We are seeking nominations 
for two non-federal, public members at this time, due to turnover of 
committee membership. Nominations will be accepted between July 31 and 
August 31, 2018.
    Who is Eligible: Nominations are encouraged for new or 
reappointment of non-federal public members who can provide the public 
and/or patient perspectives to discussions of issues considered by the 
Committee. Self-nominations and nominations of other individuals are 
both permitted. Only one nomination per individual is required. 
Multiple nominations for the same individual will not increase 
likelihood of selection. Non-federal, public members may be selected 
from the pool of submitted nominations or other sources as needed to 
meet statutory requirements and to form a balanced committee that 
represents the diversity within the muscular dystrophy communities. 
Nominations are especially encouraged from leaders or representatives 
of muscular dystrophy research, advocacy, or service organizations, 
individuals with muscular dystrophy or their parents or guardians. In 
accordance with White House Office of Management and Budget guidelines 
(FR Doc. 2014- 19140), federally-registered lobbyists are not eligible.
    Committee Composition: The Department strives to ensure that the 
membership of HHS Federal advisory committees is fairly balanced in 
terms of points of view represented and the committee's function. Every 
effort is made to ensure that the views of all genders, all ethnic and 
racial groups, and people with disabilities are

[[Page 35667]]

represented on HHS Federal advisory committees and, therefore, the 
Department encourages nominations of qualified candidates from these 
groups. The Department also encourages geographic diversity in the 
composition of the Committee. Appointment to this Committee shall be 
made without discrimination on the basis of age, race, ethnicity, 
gender, sexual orientation, disability, and cultural, religious, or 
socioeconomic status. Requests for reasonable accommodation to enable 
participation on the Committee should be indicated in the nomination 
submission.
    Member Terms: Non-Federal public members of the Committee serve for 
a term of 3 years, and may serve for an unlimited number of terms if 
reappointed. Members may serve after the expiration of their terms, 
until their successors have taken office.
    Meetings and Travel: As specified by Public Law 113-166, the MDCC 
``shall meet no fewer than two times per calendar year.'' Travel 
expenses are provided for non-federal public Committee members to 
facilitate attendance at in-person meetings. Members are expected to 
make every effort to attend all full committee meetings, twice per 
year, either in person or via remote access. Participation in relevant 
subcommittee, working and planning group meetings, and workshops, is 
also encouraged.
    Submission Instructions and Deadline: Nominations are due by 5 p.m. 
EDT on August 31, 2018, and should be sent to Glen Nuckolls, Ph.D., by 
email to <a href="/cdn-cgi/l/email-protection#ddb3a8beb6b2b1b1ba9db3b4b3b9aef3b3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="3e504b5d55515252597e5057505a4d1050575610595148">[email protected]</span></a>.
    Nominations must include contact information for the nominee, a 
current curriculum vitae or resume of the nominee and a paragraph 
describing the qualifications of the person to represent some 
portion(s) of the muscular dystrophy research, advocacy and/or patient 
care communities.
    More information about the MDCC is available at https://mdcc.nih.gov/.

     Dated: July 24, 2018.
Walter J. Koroshetz,
Director, National Institute of Neurological Disorders and Stroke, 
National Institutes of Health.
[FR Doc. 2018-16112 Filed 7-26-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>